Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients

BACKGROUND: Kidney transplantation has improved survival and quality of life for patients with end-stage renal disease. Despite excellent short-term results due to better and more potent immunosuppressive drugs, long-term survival of transplanted kidneys has not improved accordingly in the last deca...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinders, Marlies EJ, Bank, Jonna R, Dreyer, Geertje J, Roelofs, Helene, Heidt, Sebastian, Roelen, Dave L, Huurman, Volkert AL, Lindeman, Jan, van Kooten, Cees, Claas, Frans HJ, Fibbe, Wim E, Rabelink, Ton J, de Fijter, Johan W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273432/
https://www.ncbi.nlm.nih.gov/pubmed/25491391
http://dx.doi.org/10.1186/s12967-014-0331-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273432/
https://www.ncbi.nlm.nih.gov/pubmed/25491391
http://dx.doi.org/10.1186/s12967-014-0331-x

Ejemplares similares